Receptor-mediated activation of phosphatidylcholine phosphatidohydrolase or phospholipase D (PLD) was studied in Chinese hamster ovary (CHO) cells expressing the cholecystokinin-A (CCK-A) receptor. Cells were labelled with [$H]myristic acid for 24 h and PLD-catalysed [$H]phosphatidylethanol formation was measured in the presence of 1 % (v\v) ethanol. Cholecystokinin-(26-33)-peptide amide (CCK ) ) increased PLD activity both time-and dose-dependently. Maximal activation of protein kinase C (PKC) with 1 µM PMA or sustained elevation of the cytosolic free Ca# + concentration ([Ca# + ] i ) with 1 µM thapsigargin increased PLD activity to 50 % and 70 % of the maximal value obtained with CCK ) respectively. The stimulatory effects of CCK ) , PMA and thapsigargin were abolished in cells in which PKC was downregulated or inhibited by chelerythrine. PMA\Ca# + -stimulated PLD activity was absent in a homogenate
INTRODUCTION
Many hormones, neurotransmitters and growth factors use lipidderived signalling molecules to exert their biological effects. A well-elucidated pathway involves the 1-phosphatidylinositol phosphodiesterase [EC 3.1.4.10 ; phospholipase C (PLC)]-catalysed hydrolysis of inositol phospholipids to yield Ins(1,4,5)P $ , releasing calcium from the endoplasmic reticulum [1] , and 1,2-diacylglycerol (DAG) which activates protein kinase C (EC 2.7.1.37 ; PKC) [2] . This pathway is activated both via receptors that couple to a G-protein to activate PLC-β and receptors that regulate intrinsic and extrinsic tyrosine kinases to activate PLC-γ [3] [4] [5] .
It is widely observed that agonists that stimulate the enzymic breakdown of inositol phospholipids to increase the concentration of cytosolic free Ca# + ([Ca# + ] i ) and activate PKC also promote the hydrolysis of phosphatidylcholine (PtdCho) to yield choline and phosphatidic acid [5, 6] . It has been suggested that phosphatidylcholine phosphatidohydrolase [EC 3.1.4.4 ; phospholipase D (PLD)] is responsible for this agonist-induced breakdown of PtdCho [3] . Indeed, partially purified mammalian PLD has been shown to be highly selective for this phospholipid [3] . Moreover, agonists which stimulate the hydrolysis of PtdCho also cause the formation of phosphatidylalcohols as a result of the PLD-catalysed transphosphatidylation 8 , cholecystokinin-(26-33)-peptide amide ; DAG, 1,2-diacylglycerol ; DMEM, Dulbecco's modified Eagle's medium ; FCS, fetal-calf serum ; PAF, plateletactivating factor ; PKC, protein kinase C ; PLC, phospholipase C (1-phosphatidylinositol phosphodiesterase) ; PLD, phospholipase D (phosphatidylcholine phosphatidohydrolase) ; PtdCho, phosphatidylcholine ; PtdEth, phosphatidylethanol. 1 To whom correspondence should be addressed (e-mail P.Willems!bioch.kun.nl).
of PKC-downregulated cells but could be restored upon addition of purified rat brain PKC. CCK ) -induced PLD activation was inhibited by 90 % in the absence of external Ca# + , demonstrating that receptor-mediated activation of PKC in itself does not significantly add to PLD activation but requires a sustained increase in [Ca# + ] i . Taken together, the results presented demonstrate that, in CHO-CCK-A cells, receptor-mediated PLD activation is completely dependent on PKC, but that the extent to which PLD becomes activated depends largely, if not entirely, on the magnitude and duration of the agonist-induced increase in
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reaction [7] . To date, the physiological relevance of agonistinduced PtdCho hydrolysis is unclear. However, it has been proposed that phosphatidic acid is rapidly converted into DAG to activate PKC [2] .
Although Ca# + and PKC have been identified as important activators of PLD, their relative importance in agonist-induced PLD activation is still poorly defined [6, 8, 9] . In intact cells, receptor-mediated PLD activation can be mimicked by phorbol esters, which activate PKC, and Ca# + ionophores, which increase [Ca# + ] i [5, [9] [10] [11] . It is generally observed that phorbol esters are much more effective than receptor agonists. However, preliminary experiments, using Chinese hamster ovary (CHO) cells stably expressing the cholecystokinin-A receptor (CHO-CCK-A cells), revealed that in this cell type the phorbol ester PMA was less effective than cholecystokinin-(26-33)-peptide amide (CCK )
). This might suggest the presence of an additional pathway in CCK-induced PLD activation. To investigate this possibility, we studied the mechanism of CCK ) -induced PLD activation in CHO-CCK-A in more detail.
The results presented demonstrate that PKC in itself is indispensable for receptor-mediated PLD activation and that the extent to which PLD becomes activated depends largely, if not entirely, on the duration and magnitude of the agonist-induced increase in [Ca# + ] i .
MATERIALS AND METHODS

Materials
CCK )
, PMA, leupeptin and 2,2,4-trimethylpentane were obtained from Sigma (St. Louis, MO, U.S.A.) and thapsigargin from LC Services (Woburn, MA, U.S.A.). PMSF was purchased was from SERVA (Heidelberg, Germany) and [9,10( 
Development of a stable CHO-CCK-A cell line
The development of a stable CHO-CCK-A cell line has been described in detail previously [12] .
PLD measurements in CHO-CCK-A cells
CHO-CCK-A cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10 % (v\v) fetalcalf serum (FCS), in a water-saturated atmosphere containing 5 % CO # at 37 mC. For PLD measurements, the cells were subcultured in 12-well plates (2.2i10& cells\well) and labelled with [$H]myristic acid (3 µCi\ml) for 24 h. At the end of the labelling period, the cells were washed and incubated in DMEM without FCS for 3 h. In PKC downregulation experiments, PMA (0.1 µM) was added at the beginning of either the labelling (24 h PMA treatment) or the incubation with FCS-free DMEM (3 h PMA treatment). Subsequently, the cells were washed and incubated in DMEM containing 1 % (v\v) ethanol for the indicated period of time. Ca# + -free experiments were performed with minimal essential medium to which no Ca# + was added and which contained in addition 0.5 mM EGTA. At the indicated time, the medium was aspirated and the reaction was quenched by the addition of 1 ml of ice-cold methanol. The cells were scraped off and the mixture was transferred into a lipid tube (Sarstedt, Essen, Germany). Lipids were extracted according to the method described by Bligh and Dyer [13] . Briefly, 500 µl of chloroform and 400 µl of water were added and the mixture was mixed vigorously. Phase separation was achieved by addition of 400 µl of chloroform and 400 µl of water followed by centrifugation. After collection of the lower organic phase, the aqueous phase was extracted again and the combined organic phases were blown to dryness with N # .
Separation of labelled phospholipids
The dried extracts were dissolved in 20 µl of chloroform\ methanol (9 : 1, v\v) and the lipids were separated by TLC using potassium oxalate-treated silica-gel 60 HPTLC plates. The plates were developed with the upper phase of a mixture of ethyl acetate\2,2,4-trimethylpentane\acetic acid\water (13 : 2 : 3 : 10, by vol.). Radioactive spots corresponding to authentic lipid standards were visualized by I # -staining and scraped off. Radioactivity was measured by liquid-scintillation spectrometry.
PLD measurements in CHO-CCK-A homogenates
PLD activity was measured in cell homogenates according to the method of Ohguchi et al. [14] as described previously [15] . Briefly, CHO-CCK-A cells were grown to confluence in the presence of [$H]myristic acid (2 µCi\ml) for 48 h. Before homogenization, the cells were washed and incubated in DMEM without FCS for 3 h. In PKC downregulation experiments, PMA (0.1 µM) was added either 3 or 24 h before homogenization. At the end of the incubation period, the cells were washed twice with an ice-cold homogenization solution containing 100 mM KCl, 3 mM NaCl, 5 mM MgCl # , 1 mM EGTA, 5 mM dithiothreitol, 0.5 mM PMSF, 10 µg\ml leupeptin and 25 mM Hepes, adjusted with Tris to pH 7.4 and collected by scraping. The cells were subsequently homogenized at 4 mC using a Potter-Elvehjem homogenizer (glass-Teflon) by 10 strokes at 500 rev.\min, 5 strokes at 1000 rev.\min and 5 strokes at 1200 rev.\min. Unbroken cells were removed by centrifugation at 50 g for 5 min. For PLD measurements, aliquots of the homogenate were taken and 0.5 mM Mg-ATP and 1 % (v\v) ethanol were added with or without PMA and CaCl # at final concentrations of 0.1 µM and 0.5 mM respectively. The homogenate was incubated for 30 min at 37 mC. The reaction was quenched with 1 ml of icecold methanol and lipids were extracted and separated as described above.
Partially purified PKC from rat brain
Partially purified PKC, to be added to homogenates of CHO-CCK-A cells in which PKC was downregulated, was prepared from rat brain essentially as described previously [16] . Briefly, rat brain tissue was homogenized in a buffer containing 20 mM Tris\HCl (pH 7.5), 0.25 M sucrose, 10 mM EGTA, 2 mM EDTA, 0.2 mg\ml soybean trypsin inhibitor, 5 mM dithiothreitol, 1 mM PMSF, 10 µg\ml aprotinin and 10 µg\ml leupeptin. The homogenate was applied to a protamine-agarose column. Non-specifically bound protein was eluted with a buffer containing 20 mM Tris\HCl (pH 7.5), 2 mM EDTA, 2 mM EGTA, 1 mM dithiothreitol, 10 mM MgCl # and 1 M KCl. Subsequently, PKC was eluted with the same buffer containing 0.7 M KCl and 1 mM ATP. Western blot analysis revealed the presence of PKC-α, -β, -γ, -δ, -ε, -ζ, -η and -θ.
Fluorescence measurements in suspensions of CHO-CCK-A cells
Measurement of the [Ca# + ] i in CHO-CCK-A cells has been described in detail previously [17] [18] [19] . In brief, cells were loaded with the specific fluorescent calcium indicator, fura-2. Fluorescence measurements were carried out at 37 mC and the fluorescence emission ratio was monitored as a measure of [Ca# + ] i at 490 nm after excitation at 340 and 380 nm.
PKC-isotype measurements in CHO-CCK-A cells
PKC-isotype measurements were performed as described in detail previously [12, 18] .
Analysis of the data
The results presented are the meanspS.E.M. of the number of experiments indicated in the text. Paired Student's t-tests were used to determine statistical differences (P 0.05). 8 (Figure 1 ). The time course of the stimulatory effect of 10 nM CCK ) revealed that the rate of [$H]PtdEth formation was highest during the first 3 min of stimulation, after which it decreased to the significantly lower levels reached at 10 min and maintained for at least another 20 min. CCK ) -induced [$H]PtdEth formation was dose-dependent and maximal stimulation was obtained with 10 nM CCK ) (results not shown).
RESULTS
Time course of CCK
With PMA the rate of [$H]PtdEth formation was relatively constant during the first 10 min and, depending on the PMA concentration, either remained constant (0.1 µM), decreased markedly (0.3 µM), or even fell back to zero (1 µM), thereafter. This finding shows that the PMA response rapidly desensitized with higher PMA concentrations. Compared with CCK ) , the effect of PMA (1 µM) was significantly lower at all three measuring points. When added simultaneously, PMA (1 µM) neither potentiated nor inhibited the effect of 10 nM CCK ) . This demonstrates that the mechanism underlying desensitization of the PMA response did not affect the CCK ) response.
Comparison of CCK 8 -, thapsigargin-and PMA-stimulated [ 3 H]PtdEth formation in CHO-CCK-A cells
In addition to stimulating PLD, 10 nM CCK ) evoked a rapid and sustained increase in the average cytosolic free Ca# + concentration ([Ca# + ] i,av ) in a suspension of CHO-CCK-A cells ( Figure 2 ). To study the relative importance of this sustained
PtdEth formation, cells were stimulated with the sesquiterpene lactone thapsigargin. Thapsigargin inhibits the endoplasmic reticulum Ca# + -ATPase [20] , leading to depletion of intracellular Ca# + stores and thus to an increase in store-regulated Ca# + entry [21] . As a result, [Ca# + ] i remains elevated for a prolonged period of time (Figure 2) . . The effect of thapsigargin was not significantly different from that of PMA, which amounted to 50 % of the value obtained with 10 nM CCK ) . The stimulatory effects of 1 µM thapsigargin and 1 µM PMA were more than additive and the amount of [$H]PtdEth formed as a result of the combined action of both drugs was 1.4-fold higher than that obtained with 10 nM CCK )
. Interestingly, PMA, when added at a 1000-fold lower concentration of 1 nM, did not increase PLD activity by itself, but significantly potentiated the stimulatory effect of 1 µM thapsigargin to 100 % (S.E.M. l 10, n l 3) of the value obtained with 10 nM CCK ) .
Effect of protein kinase inhibitors on CCK 8 -, thapsigargin-and PMA-stimulated [ 3 H]PtdEth formation in CHO-CCK-A cells
Both staurosporine (0.1 µM), a general inhibitor of protein kinase activity [22] , and chelerythrine (50 µM), a specific inhibitor of PKC [23] , completely inhibited the stimulatory effect of PMA ( Figure 3) . However, when added in combination with either CCK ) , thapsigargin or the combination of PMA and thapsigargin, staurosporine invariably reduced the increase in (Figure 2 ). Under these conditions the increase in [$H]PtdEth in response to 10 nM CCK ) was dramatically reduced by 87.8 % (S.E.M. l 2.5, n l 4). In contrast, the stimulatory effect of 1 µM PMA was even enhanced in the absence of external Ca# + by 63.4 % (S.E.M. l 9.8, n l 4).
Effect of PKC downregulation on CCK 8 -, PMA-and thapsigargininduced [ 3 H]PtdEth formation in CHO-CCK-A cells
Immunoblotting revealed that CHO-CCK-A cells contained detectable amounts of PKC-α, PKC-ε and PKC-ζ. These three PKC isotypes were differentially downregulated during prolonged PMA (0.1 µM) treatment. The amount of PKC-α was decreased by 94 % after 3 h of incubation in the presence of PMA, whereas PKC-ε was maximally decreased after 24 h of PMA treatment (Table 1 ). In contrast, the amount of PKC-ζ remained unchanged. The preferential decrease in PKC-α was accompanied by a rapid decrease in CCK ) -stimulated [$H]PtdEth formation. The response to 10 nM CCK ) was abolished 3 h after the onset of PMA treatment. Similarly, the stimulatory effect of thapsigargin was completely inhibited at 3 h of PMA treatment.
Effect of partially purified PKC on PMA/Ca 2 + -stimulated PLD activity in homogenates of PKC-downregulated CHO-CCK-A cells
Preleminary experiments to determine the optimal concentrations of PMA and CaCl # revealed that with CaCl # alone a maximal increase above basal (65 % of the value obtained with 0.1 µM PMA and 0.5 mM CaCl # ) was obtained at a concentration of 
H]PtdEth formation and PKC-α, -ε and -ζ levels in CHO-CCK-A cells
CHO-CCK-A cells, labelled with [
3 H]myristic acid for 24 h, were incubated in the absence (0 h PMA) or presence of 0.1 µM PMA for either 3 h or 24 h. Subsequently, cells were stimulated with 10 nM CCK 8 , 0.1 µM PMA or 1 µM thapsigargin in the presence of 1 % (v/v) ethanol for 10 min. The reaction was quenched at the indicated time and the lipids were separated by HPTLC. Radioactive spots were scraped off and radioactivity was measured by liquid-scintillation spectroscopy. In each experiment, the amount of [ 3 H]PtdEth present in untreated cells stimulated with 10 nM CCK 8 is set at 100 %, to which all other values are related. Except for thapsigargin and 24 h PMA, the values presented are the meanspS.E.M. of three experiments. For PKC-isotype measurements, total cell lysates were subjected to SDS/PAGE followed by Western blotting. Membranes were incubated with PKC-isotype-specific antibodies in the presence (aspecific staining) and absence (total staining) of the corresponding isotypespecific peptides. PKC-specific bands were quantified densitometrically. In each experiment, the mean absorbance of the untreated control is set at 100 %, to which all other values are related. The results presented are the meanspS.E. 0.5 mM. In the presence of 0.5 mM CaCl # , PMA further increased PLD activity to the maximum reached at 0.1 µM. The increase above basal levels with 0.1 µM PMA alone amounted to only 13 % of the value obtained with 0.1 µM PMA and 0.5 mM CaCl # . Importantly, this activation profile of PLD is identical with that of PKC. Figure 4 shows that addition of 0.1 µM PMA and 0.5 mM CaCl # resulted in a 2.5-fold increase in PLD activity in a homogenate of CHO-CCK-A cells. PMA\Ca# + -stimulated PLD activity depended largely, but not entirely, on ATP, since without its addition only a 1.4-fold (S.E.M. l 0.1, n l 4) increase in PLD activity was observed. PMA\Ca# + -stimulated PLD activity was dramatically decreased in homogenates of cells pretreated with PMA for 3 h and abolished after 24 h of phorbol ester treatment (Figure 4 ). Addition of partially purified PKC from rat brain did not affect PMA\Ca# + -stimulated PLD activity in untreated cells, while virtually completely restoring this activity in homogenates from PMA-treated cells. Addition of PKC had no significant effect on PLD activity measured in the absence of PMA and CaCl # .
DISCUSSION
The present study demonstrates that CCK ) increases PLD activity in CHO-CCK-A cells solely through PKC and an increase in [Ca# + ] i , and that no other pathway is involved. This conclusion is based on the following observations : (i) PKC, most probably PKC-α, is indispensable for receptor-mediated PLD activation ; (ii) receptor-mediated PKC activation in itself hardly increases PLD activity ; and (iii) the extent to which PLD becomes activated during receptor-mediated PLD activation depends largely, if not completely, on the duration and magnitude of the agonistinduced increase in [Ca# + ] i . (i) Evidence for the absolute requirement of CCK ) -induced PLD activation for PKC comes from the following observations. First, neither CCK ) nor PMA increased PLD activity in PKC downregulated cells, notwithstanding the fact that CCK ) , as has been demonstrated previously [12] , causes a sustained increase in [Ca# + ] i in PMA-treated cells. Consistent with the latter finding, thapsigargin did not increase PLD activity in PKC downregulated cells. Secondly, the PKC inhibitor chelerythrine completely blocked the stimulatory effects of CCK ) , PMA, thapsigargin and the combination of the latter two drugs. Thirdly, PMA\Ca# + -stimulated PLD activity was completely inhibited in a homogenate of PKC-downregulated cells but could be restored after addition of partially purified PKC from rat brain.
An absolute requirement of agonist-, phorbol ester-and Ca# + -induced PLD activation for PKC has been reported in a wide variety of cell types [24] [25] [26] [27] , including CHO cells expressing the platelet-activating factor (PAF) receptor (CHO-PAF cells) [28] . Noticeably, these studies did not take into account the possibility that prolonged treatment with phorbol ester might have led to downregulation of factors other than PKC that may play a role in receptor-mediated PLD activation. However, given the finding that the effect of CCK ) on PLD activity depended largely on its effect on [Ca# + ] i , the observation that PMA\Ca# + -stimulated PLD activity in a homogenate of PKC-downregulated cells was completely restored after addition of partially purified PKC does not support this possibility.
Evidence has been provided that AlF % − -insensitive monomeric G-proteins, such as ARF and Rho, can directly activate PLD [29] . Thus far, however, the mechanism by which agonists activate these small G-proteins is unknown. In a recent study it was demonstrated that AlF % − stimulation of PLD activity in Saos-2 cells through heterotrimeric G-proteins was accompanied by redistribution of ARF and RhoA to the membrane [30] . Since the effects of AlF % − and phorbol ester were more than additive, and preferential downregulation of PKC-α by chronic phorbol ester treatment abolished the effect of the phorbol ester, but not that of AlF % − , it was proposed that these small G-proteins act synergistically with PKC in receptor-mediated PLD activation. Of note is the similar additive effect between agonist and phorbol ester that was observed in CHO cells expressing the V1a vasopressin receptor (CHO-V1a cells) and regarded as indicative of the existence of different mechanisms of PLD activation [31] . However, the present finding that preferential downregulation of PKC-α completely inhibited the action of CCK ) supports the idea that no factors other than PKC are involved in agonistinduced PLD activation in CHO-CCK-A cells.
Immunoblot analysis revealed that the loss of PMA-and CCK )
-induced PLD activation, as observed during chronic PMA treatment, correlated best with the disappearance of PKC-α. In contrast with this study, preferential downregulation of PKC-α in CHO-PAF cells by 6 h exposure to 0.1 µM phorbol ester has previously been found not to completely inhibit agonist-and phorbol ester-induced PLD activation [32] . Similarly, in CHOV1a cells, 3 h exposure to 0.1 µM phorbol ester did not even reduce agonist-induced PLD activation by half [31] , whereas the effect of the phorbol ester was virtually completely inhibited [31, 33] . The possibility that the V1a receptor activates an additional PKC-independent pathway leading to PLD activation is unlikely, since agonist-induced PLD activation was completely inhibited by calphostin-C [31] .
Intriguingly, despite the fact that CCK ) , thapsigargin and the combination of PMA and thapsigargin increased PLD activity to a different extent, staurosporine invariably reduced stimulated PLD activity to 30 % of the value obtained with CCK ) alone. Given the absolute requirement for PKC and the fact that staurosporine acts as a competitive inhibitor at the ATP-binding site [22] , this suggests that the greater part of the agonist-induced increase in PLD activity occurs in a phosphorylation-dependent manner. The smaller staurosporine-resistant part may then reflect the ATP-independent PKC-mediated pathway originally postulated by Conricode et al. [34] . In agreement with this idea, PMA\Ca# + -stimulated PLD activity in a homogenate of CHO-CCK-A cells was shown to depend largely, but not entirely, on the presence of ATP in the assay medium. Also in agreement with this idea, chelerythrine, which acts in a competitive fashion with respect to the phosphate acceptor [23] , completely inhibited the CCK-induced increase in PLD activity. Staurosporine abolished PMA-induced PLD activation, suggesting that the phorbol ester acts entirely via the phosphorylation-dependent pathway. This then suggests that the ATP-independent pathway is activated by the sustained increase in [Ca# + ] i observed with CCK ) and thapsigargin.
(ii) The observation that in the absence of external Ca# + the effect of CCK ) was inhibited by 90 % demonstrates that receptormediated PKC activation in itself only marginally contributes to agonist-induced PLD activation. The absence of external Ca# + prevented [Ca# + ] i from being increased for prolonged periods of time, demonstrating that a sustained increase in [Ca# + ] i is required for full activation of PLD. In contrast with the present study, agonist and phorbol ester displayed the same maximal effect in CHO-V1a [31] and CHO-PAF [28] cells. In view of the above discussion, however, this discrepancy might be explained by the higher magnitude of the sustained increase in [Ca# + ] i in CHO-CCK-A cells as compared with CHO-V1a cells.
(iii) The finding that thapsigargin increased PLD activity to 70 % of the value obtained with 10 nM CCK ) suggests that only 30 % of receptor-induced PLD activation depends on DAGmediated PKC activation. This is in agreement with the observation that low-level PKC activation by 1 nM PMA, which did not affect PLD activity by itself, potentiated the stimulatory effect of thapsigargin to a level similar to that obtained with 10 nM CCK )
. The thapsigargin response was further increased to 138 % of the value obtained with 10 nM CCK ) by a PMA concentration (1 µM) that was maximally effective in stimulating PLD activity by itself. Surprisingly, the response to the latter PMA concentration was also increased under conditions when [Ca# + ] i was most likely to be decreased as a result of the omission of Ca# + from the medium. At present, the reason for this apparent discrepancy is unclear.
Taken together, the present observations are consistent with the idea that agonist-induced PLD activation in CHO-CCK-A cells occurs in a PKC-dependent manner, most probably involving both a phosphorylating and a non-phosphorylating mechanism. Despite its indispensability, however, the contribution of PKC activation alone in receptor-mediated PLD activation is low compared with that of the increase in [Ca# + ] i .
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